From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
General schema showing the relationships of the lipidome to the genome, transcriptome, proteome and metabolome. Lipids also regulate protein function and gene transcription as part of a dynamic "interactome" within the cell.

Lipidomics may be defined as the large-scale study of pathways and networks of cellular lipids in biological systems[1] [2]. The word "lipidome" is used to describe the complete lipid profile within a cell, tissue or organism and is a subset of the "metabolome" which also includes the three other major classes of biological molecules: proteins/amino-acids, sugars and nucleic acids. Lipidomics is a relatively recent research field that has been driven by rapid advances in technologies such as mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, fluorescence spectroscopy and computational methods, coupled with the recognition of the role of lipids in many metabolic diseases such as obesity, atherosclerosis, stroke, hypertension and diabetes. This rapidly expanding field[3] complements the huge progress made in genomics and proteomics, all of which constitute the family of systems biology.

Lipidomics research involves the identification and quantitation of the thousands of cellular lipid molecular species and their interactions with other lipids, proteins, and other metabolites. Investigators in lipidomics examine the structures, functions, interactions, and dynamics of cellular lipids and the changes that occur during perturbation of the system.

Han and Gross[4] first defined the field of lipidomics through integrating the specific chemical properties inherent in lipid molecular species with a comprehensive mass spectrometric approach. Although lipidomics is under the umbrella of the more general field of "metabolomics", lipidomics is itself a distinct discipline due to the uniqueness and functional specificity of lipids relative to other metabolites.

In lipidomic research, a vast amount of information quantitatively describing the spatial and temporal alterations in the content and composition of different lipid molecular species is accrued after perturbation of a cell through changes in its physiological or pathological state. Information obtained from these studies facilitates mechanistic insights into changes in cellular function. Therefore, lipidomic studies play an essential role in defining the biochemical mechanisms of lipid-related disease processes through identifying alterations in cellular lipid metabolism, trafficking and homeostasis. The growing attention on lipid research is also seen from the initiatives underway of the LIPID Metabolites And Pathways Strategy (LIPID MAPS Consortium).[5] and The European Lipidomics Initiative (ELIfe)[6].

Examples of some lipids from various categories.

Structural Diversity of Lipids[edit]

Lipids are a diverse and ubiquitous group of compounds which have many key biological functions, such as acting as structural components of cell membranes, serving as energy storage sources and participating in signaling pathways. Lipids may be broadly defined as hydrophobic or amphipathic small molecules that originate entirely or in part from two distinct types of biochemical subunits or "building blocks": ketoacyl and isoprene groups.[7]. The huge structural diversity found in lipids arises from the biosynthesis of various combinations of these building blocks. For example, glycerophospholipids are composed of a glycerol backbone linked to one of approximately 10 possible headgroups and also to 2 fatty acyl/alkyl chains, which in turn may have 30 or more different molecular structures. In practice, not all possible permutations are detected experimentally, due to chain preferences depending on the cell type and also to detection limits - nevertheless several hundred distinct glycerophospholipid molecular species have been detected in mammalian cells.

Experimental techniques[edit]

Lipid Extraction[edit]

Most methods of lipid extraction and isolation from biological samples exploit the high solubility of hydrocarbon chains in organic solvents.Given the diversity in lipid classes, it is not possible to accommodate all classes with a common extraction method. The traditional Bligh/Dyer procedure [8] uses chloroform/methanol-based protocols that include phase partitioning into the organic layer. These protocols work relatively well for a wide variety of physiologically relevant lipids but they have to be adapted for complex lipid chemistries and low-abundance and labile lipid metabolites [9] [10] [11] [12] [13] [14].

Lipid Separation[edit]

The simplest method of lipid separation is the use of thin layer chromatofraphy (TLC). Although not as sensitive as other methods of lipid detection, it offers a rapid and comprehensive screening tool prior to more sensitive and sophisticated techniques. Solid-phase extraction (SPE) chromatography is useful for rapid, preparative separation of crude lipid mixtures into different lipid classes. This involves the use of prepacked columns containing silica or other stationary phases to separate glycerophospholipids, fatty acids, cholesteryl esters, glycerolipids, and sterols from crude lipid mixtures[15]. High performance liquid chromatography (HPLC or LC) is extensively used in lipidomic analysis to separate lipids prior to mass analysis. Separation can be achieved by either normal-phase HPLC or reverse-phase HPLC. For example, normal phase HPLC effectively separates glycerophospholipids on the basis of headgroup polarity[16], whereas reverse-phase HPLC effectively separates fatty acids such as eicosanoids on the basis of chain length, degreee of unsaturation and substitution[17]. HPLC of lipids may either be performed offline or online where the eluate is integrated with the ionization source of a mass spectrometer.

Lipid Detection[edit]

The progress of modern lipidomics has been greatly accelerated by the development of spectrometric methods in general and soft ionization techniques for mass spectrometry such as electrospray ionization (ESI)[4] and matrix-assisted laser desorption/ionization (MALDI)[18] in particular. "Soft" ionization does not cause extensive fragmentation, so that comprehensive detection of an entire range of lipids within a complex mixture can be correlated to experimental conditions or disease state. In addition to ESI and MALDI, the technique of atmospheric pressure chemical ionization (APCI) has become increasingly popular for the analysis of nonpolar lipids[19].

Schema showing detection of a fatty acid by LC-MS/MS using a linear ion-trap instrument and an electrospray (ESI) ion source.

ESI MS[edit]

ESI-MS was initially developed by Fenn and colleagues for analysis of biomolecules[20]. It depends on the formation of gaseous ions from polar, thermally labile and mostly non-volatile molecules and thus is completely suitable for a variety of lipids. It is a soft-ionization method that rarely disrupts the chemical nature of the analyte prior to mass analysis. Various ESI-MS methods have been developed for analysis of different classes, subclasses, and individual lipid species from biological extracts. Comprehensive reviews of the methods and their application have recently been published[21]. The major advantages of ESI-MS are high accuracy, sensitivity, reproducibility, and the applicability of the technique to complex solutions without prior derivatization. Han and coworkers have developed a method known as"shotgun lipidomics" which involves direct infusion of a crude lipid extract into an ESI source optimized for intrasource separation of lipids based on their intrinsic electrical properties[22].

MALDI MS[edit]

MALDI mass spectrometry is a laser-based soft-ionization method often used for analysis of large proteins, but has been used successfully for lipids. The lipid is mixed with a matrix, such as 2,5-dihydroxybenzoic acid, and applied to a sample holder as a small spot. A laser is fired at the spot, and the matrix absorbs the energy, which is then transferred to the analyte, resulting in ionization of the molecule. MALDI-Time-of-flight (MALDI-TOF) MS has become a very promising approach for lipidomics studies, particularly for the imaging of lipids from tissue slides[23].

APCI MS[edit]

The source for APCI is similar to ESI except that ions are formed by the interaction of the heated analyte solvent with a corona discharge needle set at a high electrical potential. Primary ions are formed immediately surrounding the needle, and these interact with the solvent to form secondary ions that ultimately ionize the sample. APCI is particularly useful for the analysis of nonpolar lipids such as triacylglycerols, sterols, and fatty acid esters[24].

Imaging Techniques[edit]

Recent developments in MALDI methods have enabled direct detection of lipids in-situ. Abundant lipid-related ions are produced from the direct analysis of thin tissue slices when sequential spectra are acquired across a tissue surface that has been coated with a MALDI matrix. Collisional activation of the molecular ions can be used to determine the lipid family and often structurally define the molecular species. This technique enables detection of phospholipids, sphingolipids and glycerolipids in tissues such as heart, kidney and brain. Furthermore distribution of many different lipid molecular species often define anatomical regions within these tissues[25].

Lipidomic Profiling[edit]

Lipid profiling is a targeted metabolomics platform that provides a comprehensive analysis of lipid species within a cell or tissue. Profiling based on electrospray ionization tandem mass spectrometry (ESI-MS/MS) is capable of providing quantitative data and is adaptable to high throughput analyses[26]. The powerful approach of transgenics, namely deletion and/or overexpression of a gene product coupled with lipidomics, can give valuable insights into the role of biochemical pathways[27]. Lipid profiling techniques have also been applied to plants[28] and microorganisms such as yeast[29]. A combination of quantitative lipidomic data in conjunction with the corresponding transcriptional data (using gene-array methods) and proteomic data (using tandem MS) enables a systems biology approach to a more in-depth understanding ofthe metabolic or signaling pathways of interest.


A major challenge for lipidomics, in particular for MS-based approaches, lies in the computational and bioinformatic demands of handling the large amount of data that arise at various stages along the chain of information acquisition and processing. Chromatographic and MS data collection requires substantial efforts in spectral alignment and statistical evaluation of fluctuations in signal intensities. Such variations have a multitude of origins, including biological variations, sample handling and analytical accuracy. As a consequence several replicates are normally required for reliable determination of lipid levels in complex mixtures. Within the last few years, a number of software packages have been developed by various companies and research groups to analyze data generated by MS profiling of metabolites, including lipids. The data processing for differential profiling usually proceed through several stages, including input file manipulation, spectral filtering, peak detection, chromatographic alignment, normalization, visualization, and data export. An example of metabolic profiling software is the freely-available Java-based Mzmine application[30]. Some software packages such as Markerview[31] include multivariate statistical analysis (for example, principal component analysis) and these will be helpful for the identification of correlations in lipid metabolites that are associated with a physiological phenotype, in particular for the development of lipid-based biomarkers.Another objective of the information technology side of lipidomics involves the construction of metabolic maps from data on lipid structures and lipid-related protein and genes. Some of these lipid pathways[32] are extremely complex, for example the mammalian glycosphingolipid pathway[33]. The establishment of searchable and interactive databases[34][35] of lipids and lipid-related genes/proteins is also an extremely important resource as a reference for the lipidomics community. Integration of these databases with MS and other experimental data, as well as with metabolic networks offers an opportunity to devise therapeutic strategies to prevent or reverse these pathological states involving dysfunction of lipid-related processes.


  1. ^ Wenk MR (2005). "The emerging field of lipidomics". Nat Rev Drug Discov. 4 (7): 594–610. doi:10.1038/nrd1776. PMID 16052242. Unknown parameter |month= ignored (help)
  2. ^ Watson AD (2006). "Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems". J. Lipid Res. 47 (10): 2101–11. doi:10.1194/jlr.R600022-JLR200. PMID 16902246. Unknown parameter |month= ignored (help)
  3. ^ Han X (2007). "Neurolipidomics: challenges and developments". Front. Biosci. 12: 2601–15. PMC 2141543. PMID 17127266.
  4. ^ a b Han X, Gross RW (2003). "Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics". J. Lipid Res. 44 (6): 1071–9. doi:10.1194/jlr.R300004-JLR200. PMID 12671038. Unknown parameter |month= ignored (help) Cite error: Invalid <ref> tag; name "pmid12671038" defined multiple times with different content (see the help page).
  5. ^ LIPID MAPS Consortium
  6. ^ European Lipidomics Initiative
  7. ^ Fahy E, Subramaniam S, Brown HA; et al. (2005). "A comprehensive classification system for lipids". J. Lipid Res. 46 (5): 839–61. PMID 15722563. Explicit use of et al. in: |author= (help)CS1 maint: Multiple names: authors list (link)
  8. ^ Bligh EG, Dyer WJ (1959). "A rapid method of total lipid extraction and purification". Can J Biochem Physiol. 37 (8): 911–7. PMID 13671378. Unknown parameter |month= ignored (help)
  9. ^ Krank J, Murphy RC, Barkley RM, Duchoslav E, McAnoy A (2007). "Qualitative analysis and quantitative assessment of changes in neutral glycerol lipid molecular species within cells". Meth. Enzymol. 432: 1–20. doi:10.1016/S0076-6879(07)32001-6. PMID 17954211.CS1 maint: Multiple names: authors list (link)
  10. ^ Ivanova PT, Milne SB, Byrne MO, Xiang Y, Brown HA (2007). "Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry". Meth. Enzymol. 432: 21–57. doi:10.1016/S0076-6879(07)32002-8. PMID 17954212.CS1 maint: Multiple names: authors list (link)
  11. ^ Deems R, Buczynski MW, Bowers-Gentry R, Harkewicz R, Dennis EA (2007). "Detection and quantitation of eicosanoids via high performance liquid chromatography-electrospray ionization-mass spectrometry". Meth. Enzymol. 432: 59–82. doi:10.1016/S0076-6879(07)32003-X. PMID 17954213.CS1 maint: Multiple names: authors list (link)
  12. ^ McDonald JG, Thompson BM, McCrum EC, Russell DW (2007). "Extraction and analysis of sterols in biological matrices by high performance liquid chromatography electrospray ionization mass spectrometry". Meth. Enzymol. 432: 145–70. doi:10.1016/S0076-6879(07)32006-5. PMID 17954216.CS1 maint: Multiple names: authors list (link)
  13. ^ Garrett TA, Guan Z, Raetz CR (2007). "Analysis of ubiquinones, dolichols, and dolichol diphosphate-oligosaccharides by liquid chromatography-electrospray ionization-mass spectrometry". Meth. Enzymol. 432: 117–43. doi:10.1016/S0076-6879(07)32005-3. PMID 17954215.CS1 maint: Multiple names: authors list (link)
  14. ^ Sullards MC, Allegood JC, Kelly S, Wang E, Haynes CA, Park H, Chen Y, Merrill AH (2007). "Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics". Meth. Enzymol. 432: 83–115. doi:10.1016/S0076-6879(07)32004-1. PMID 17954214.CS1 maint: Multiple names: authors list (link)
  15. ^ Kaluzny MA, Duncan LA, Merritt MV, Epps DE (1985). "Rapid separation of lipid classes in high yield and purity using bonded phase columns". J. Lipid Res. 26 (1): 135–40. PMID 3973509. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  16. ^ Malavolta M, Bocci F, Boselli E, Frega NG (2004). "Normal phase liquid chromatography-electrospray ionization tandem mass spectrometry analysis of phospholipid molecular species in blood mononuclear cells: application to cystic fibrosis". J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 810 (2): 173–86. doi:10.1016/j.jchromb.2004.07.001. PMID 15380713. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  17. ^ Nakamura T, Bratton DL, Murphy RC (1997). <888::AID-JMS548>3.0.CO;2-W "Analysis of epoxyeicosatrienoic and monohydroxyeicosatetraenoic acids esterified to phospholipids in human red blood cells by electrospray tandem mass spectrometry". J Mass Spectrom. 32 (8): 888–96. doi:10.1002/(SICI)1096-9888(199708)32:8<888::AID-JMS548>3.0.CO;2-W. PMID 9269087. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  18. ^ Fuchs B, Schiller J (2008). "MALDI-TOF MS analysis of lipids from cells, tissues and body fluids". Subcell. Biochem. 49: 541–65. doi:10.1007/978-1-4020-8831-5_21. PMID 18751926.
  19. ^ Byrdwell WC (2001). "Atmospheric pressure chemical ionization mass spectrometry for analysis of lipids". Lipids. 36 (4): 327–46. PMID 11383683. Unknown parameter |month= ignored (help)
  20. ^ Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM (1989). "Electrospray ionization for mass spectrometry of large biomolecules". Science (journal). 246 (4926): 64–71. PMID 2675315. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  21. ^ Murphy RC, Fiedler J, Hevko J (2001). "Analysis of nonvolatile lipids by mass spectrometry". Chem. Rev. 101 (2): 479–526. PMID 11712255. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  22. ^ Gross RW, Han X (2007). "Lipidomics in diabetes and the metabolic syndrome". Meth. Enzymol. 433: 73–90. doi:10.1016/S0076-6879(07)33004-8. PMID 17954229.
  23. ^ Schiller J, Suss R, Fuchs B, Muller M, Zschornig O, Arnold K (2007). "MALDI-TOF MS in lipidomics". Front. Biosci. 12: 2568–79. PMID 17127263.CS1 maint: Multiple names: authors list (link)
  24. ^ Byrdwell WC (2008). "Dual parallel liquid chromatography with dual mass spectrometry (LC2/MS2) for a total lipid analysis". Front. Biosci. 13: 100–20. PMID 17981531.
  25. ^ Murphy RC, Hankin JA, Barkley RM (2008). "Imaging of lipid species by MALDI mass spectrometry". J. Lipid Res. doi:10.1194/jlr.R800051-JLR200. PMID 19050313. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  26. ^ Lipid profiling of a mouse macrophage cell line (LIPID MAPS)
  27. ^ Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan L, Van Dyke TE (2003). "Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators". J. Immunol. 171 (12): 6856–65. PMID 14662892. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  28. ^ Devaiah SP, Roth MR, Baughman E, Li M, Tamura P, Jeannotte R, Welti R, Wang X (2006). "Quantitative profiling of polar glycerolipid species from organs of wild-type Arabidopsis and a phospholipase Dalpha1 knockout mutant". Phytochemistry. 67 (17): 1907–24. doi:10.1016/j.phytochem.2006.06.005. PMID 16843506. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  29. ^ Ejsing CS, Moehring T, Bahr U, Duchoslav E, Karas M, Simons K, Shevchenko A (2006). "Collision-induced dissociation pathways of yeast sphingolipids and their molecular profiling in total lipid extracts: a study by quadrupole TOF and linear ion trap-orbitrap mass spectrometry". J Mass Spectrom. 41 (3): 372–89. doi:10.1002/jms.997. PMID 16498600. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  30. ^ Katajamaa M, Miettinen J, Oresic M (2006). "MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data". Bioinformatics. 22 (5): 634–6. doi:10.1093/bioinformatics/btk039. PMID 16403790. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  31. ^ Lutz U, Lutz RW, Lutz WK (2006). "Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender". Anal. Chem. 78 (13): 4564–71. doi:10.1021/ac0522299. PMID 16808466. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  32. ^ Okuda S, Yamada T, Hamajima M, Itoh M, Katayama T, Bork P, Goto S, Kanehisa M (2008). "KEGG Atlas mapping for global analysis of metabolic pathways". Nucleic Acids Res. 36 (Web Server issue): W423–6. doi:10.1093/nar/gkn282. PMC 2447737. PMID 18477636. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  33. ^ SphingoMAP
  34. ^ Sud M, Fahy E, Cotter D, Brown A, Dennis EA, Glass CK, Merrill AH, Murphy RC, Raetz CR, Russell DW, Subramaniam S (2007). "LMSD: LIPID MAPS structure database". Nucleic Acids Res. 35 (Database issue): D527–32. doi:10.1093/nar/gkl838. PMC 1669719. PMID 17098933. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
  35. ^ Cotter D, Maer A, Guda C, Saunders B, Subramaniam S (2006). "LMPD: LIPID MAPS proteome database". Nucleic Acids Res. 34 (Database issue): D507–10. doi:10.1093/nar/gkj122. PMC 1347484. PMID 16381922. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)

See also[edit]

External links[edit]